5-HT1D receptor immunoreactivity in the sphenopalatine ganglion: implications for the efficacy of triptans in the treatment of autonomic signs associated with cluster headache

Headache

Volumn 51, Issue 3, 2011, Pages 392-402

  Ivanusic, Jason J ^a   Kwok, Matthew M K ^a   Ahn, Andrew H ^c   Jennings, Ernest A ^a,b  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b JAMES COOK UNIVERSITY   (Australia)

^c UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

5 HT1D; Axon reflex; Calcitonin gene related peptide; Parasympathetic; Sumatriptan; Trigeminal

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; SEROTONIN 1D RECEPTOR; TRIPTAN DERIVATIVE; VESICULAR ACETYLCHOLINE TRANSPORTER;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN BLOOD VESSEL; CLUSTER HEADACHE; DRUG EFFICACY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LACRIMAL GLAND; NERVE CELL; NERVE ENDING; NONHUMAN; NOSE MUCOSA; PARASYMPATHETIC GANGLION; PARASYMPATHETIC NERVE; PARASYMPATHETIC NERVE CELL; PERIKARYON; PRIORITY JOURNAL; PTERYGOPALATINE GANGLION; RAT; TRIGEMINUS GANGLION;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; CALCITONIN GENE-RELATED PEPTIDE; CLUSTER HEADACHE; GANGLIA, PARASYMPATHETIC; IMMUNOHISTOCHEMISTRY; LACRIMAL APPARATUS; MODELS, ANIMAL; NASAL MUCOSA; PALATE, HARD; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT1D; SPHENOID BONE; TREATMENT OUTCOME; TRYPTAMINES;

EID: 79952275911     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2011.01843.x     Document Type: Article

References (37)

1. Goadsby PJ. Pathophysiology of cluster headache: A trigeminal autonomic cephalgia. Lancet Neurol. 2002;1:251-257. (Pubitemid 37159187)
2. Leroux E, Ducros A. Cluster headache. Orphanet J Rare Dis. 2008;3:20.
3. Nappi G, Micieli G, Cavallini A, Zanferrari C, Sandrini G, Manzoni GC. Accompanying symptoms of cluster attacks:Their relevance to the diagnostic criteria. Cephalalgia. 1992;12:165-168.
4. Obermann M, Yoon MS, Dommes P, et al. Prevalence of trigeminal autonomic symptoms in migraine: A population-based study. Cephalalgia. 2007;27:504-509. (Pubitemid 46848914)
5. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of Migraine. Neuroscience. 2009;161:327-341.
6. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol. 1990;28:183-187. (Pubitemid 20244522)
7. Moskowitz MA. Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine. Trends Pharmacol Sci. 1992;13:307-311.
8. Hardebo JE, Elner A. Nerves and vessels in the pterygopalatine fossa and symptoms of cluster headache. Headache. 1987;27:528-532.
9. Ekbom K, Krabbe A, Micieli G, et al. Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group. Cephalalgia. 1995;15:230-236.
10. Ekbom K, Monstad I, Prusinski A, Cole JA, Pilgrim AJ, Noronha D. Subcutaneous sumatriptan in the acute treatment of cluster headache: A dose comparison study. The Sumatriptan Cluster Headache Study Group. Acta Neurol Scand. 1993;88:63-69. (Pubitemid 23210979)
11. Hardebo JE. Subcutaneous sumatriptan in cluster headache: A time study of the effect on pain and autonomic symptoms. Headache. 1993;33:18-21. (Pubitemid 23057821)
12. Gobel H, Lindner V, Heinze A, Ribbat M, Deuschl G. Acute therapy for cluster headache with sumatriptan: Findings of a one-year long-term study. Neurology. 1998;51:908-911. (Pubitemid 28449291)
13. Torelli P, Manzoni GC. Cluster headache: Symptomatic treatment. Neurol Sci. 2004;25(Suppl. 3): S119-S122. (Pubitemid 41461973)
14. Longmore J, Shaw D, Smith D, et al. Differential distribution of 5HT1D- and 5HT1B-immunoreactivity within the human trigeminocerebrovascular system: Implications for the discovery of new antimigraine drugs. Cephalalgia. 1997;17:833-842.
15. Potrebic S, Ahn AH, Skinner K, Fields HL, Basbaum AI. Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin 1D receptors: Implications for the selective antimigraine action of triptans. J Neurosci. 2003;23:10988-10997. (Pubitemid 37499709)
16. Hou M, Kanje M, Longmore J, Tajti J, Uddman R, Edvinsson L. 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: Co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase. Brain Res. 2001;909:112-120. (Pubitemid 32710124)
17. Harriott AM,Gold MS.Serotonin type 1D receptors (5HTR) are differentially distributed in nerve fibres innervating craniofacial tissues. Cephalalgia. 2008;28:933-944.
18. Schneider JS, Denaro FJ, Olazabal UE, Leard HO. Stereotaxic atlas of the trigeminal ganglion in rat, cat, and monkey. Brain Res Bull. 1981;7:93-95. (Pubitemid 11001243)
19. Suzuki N, Hardebo JE, Owman C. Origins and pathways of cerebrovascular vasoactive intestinal polypeptide-positive nerves in rat. J Cereb Blood Flow Metab. 1988;8:697-712.
20. Suzuki N, Hardebo JE, Owman C. Trigeminal fibre collaterals storing substance P and calcitonin gene-related peptide associate with ganglion cells containing choline acetyltransferase and vasoactive intestinal polypeptide in the sphenopalatine ganglion of the rat.An axon reflex modulating parasympathetic ganglionic activity? Neuroscience. 1989;30: 595-604. (Pubitemid 19197141)
21. Weihe E,TaoCheng JH, Schafer MKH,Erickson JD, Eiden LE. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles. Proc Natl Acad Sci U S A. 1996;93:3547-3552. (Pubitemid 26125658)
22. Yasuhara O, Aimi Y, Shibano A, Kimura H. Primary sensory neurons containing choline acetyltransferase of the peripheral type in the rat trigeminal ganglion and their relation to neuropeptides-, calbindin- and nitric oxide synthase-containing cells. Brain Res. 2007;1141:92-98. (Pubitemid 46365648)
23. Arvidsson U, Riedl M, Elde R, Meister B. Vesicular acetylcholine transporter (VAChT) protein:A novel and unique marker for cholinergic neurons in the central and peripheral nervous systems. J Comp Neurol. 1997;378:454-467. (Pubitemid 27061448)
24. Ito T, Hioki H, Nakamura K, et al. Gammaaminobutyric acid-containing sympathetic preganglionic neurons in rat thoracic spinal cord send their axons to the superior cervical ganglion. J Comp Neurol. 2007;502:113-125. (Pubitemid 46481933)
25. Motosugi H, Chiba T, Konno A, Kaneko T. Distribution of neuropeptides in rat pterygopalatine ganglion: Light and electron microscopic immunohistochemical studies. Arch Histol Cytol. 1992;55: 513-524. (Pubitemid 23112307)
26. Beckers HJ, Klooster J, Vrensen GF, Lamers WP. Ultrastructural identification of trigeminal nerve terminals in the pterygopalatine ganglion of rats:An anterograde tracing and immunohistochemical study. Brain Res. 1991;557:22-30.
27. Burstein R, Jakubowski M. Unitary hypothesis for multiple triggers of the pain and strain of migraine. J Comp Neurol. 2005;493:9-14. (Pubitemid 41636179)
28. Lundblad L, Lundberg JM, Brodin E, Anggard A. Origin and distribution of capsaicin-sensitive substance P-immunoreactive nerves in the nasal mucosa. Acta Otolaryngol. 1983;96:485-493. (Pubitemid 13013920)
29. Uddman R, Malm L, Sundler F. Substance-P-containing nerve fibers in the nasal mucosa. Arch Otorhinolaryngol. 1983;238:9-16. (Pubitemid 13054525)
30. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol. 1990;99:202-206. (Pubitemid 20033811)
31. Limmroth V, Katsarava Z, Liedert B, et al. An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system. Pain. 2001;92:101-106. (Pubitemid 32367941)
32. Jennings EA, Ryan RM, Christie MJ. Effects of sumatriptan on rat medullary dorsal horn neurons. Pain. 2004;111:30-37. (Pubitemid 39141004)
33. Uddman R, Hara H, Edvinsson L. Neuronal pathways to the rat middle meningeal artery revealed by retrograde tracing and immunocytochemistry. J Auton Nerv Syst. 1989;26:69-75. (Pubitemid 19075683)
34. Edvinsson L, Hara H, Uddman R. Retrograde tracing of nerve fibers to the rat middle cerebral artery with true blue: Colocalization with different peptides. J Cereb Blood Flow Metab. 1989;9: 212-218. (Pubitemid 19095855)
35. Hara H, Zhang QJ, Kuroyanagi T, Kobayashi S. Parasympathetic cerebrovascular innervation: An anterograde tracing from the sphenopalatine ganglion in the rat. Neurosurgery. 1993;32:822-827. discussion 827.
36. Suzuki N, Hardebo JE, Owman C. Origins and pathways of cerebrovascular nerves storing substance P and calcitonin gene-related peptide in rat. Neuroscience. 1989;31:427-438. (Pubitemid 19238648)
37. Edvinsson L, Elsas T, Suzuki N, Shimizu T, Lee TJ. Origin and Co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat. Microsc Res Tech. 2001;53:221-228. (Pubitemid 32378036)